» Articles » PMID: 32850756

Biodefense Implications of New-World Hantaviruses

Overview
Date 2020 Aug 28
PMID 32850756
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Hantaviruses, part of the family, are a genus of negative-sense, single-stranded RNA viruses that cause two major diseases: New-World Hantavirus Cardiopulmonary Syndrome and Old-World Hemorrhagic Fever with Renal Syndrome. Hantaviruses generally are found worldwide with each disease corresponding to their respective hemispheres. New-World Hantaviruses spread by specific rodent-host reservoirs and are categorized as emerging viruses that pose a threat to global health and security due to their high mortality rate and ease of transmission. Incidentally, reports of Hantavirus categorization as a bioweapon are often contradicted as both US National Institute of Allergy and Infectious Diseases and the Centers for Disease Control and Prevention refer to them as Category A and C bioagents respectively, each retaining qualitative levels of importance and severity. Concerns of Hantavirus being engineered into a novel bioagent has been thwarted by Hantaviruses being difficult to culture, isolate, and purify limiting its ability to be weaponized. However, the natural properties of Hantaviruses pose a threat that can be exploited by conventional and unconventional forces. This review seeks to clarify the categorization of Hantaviruses as a bioweapon, whilst defining the practicality of employing New-World Hantaviruses and their effect on armies, infrastructure, and civilian targets.

Citing Articles

HLA-E-restricted Hantaan virus-specific CD8 T cell responses enhance the control of infection in hemorrhagic fever with renal syndrome.

Tang K, Zhang Y, Li X, Zhang C, Jia X, Hu H Biosaf Health. 2025; 5(5):289-299.

PMID: 40078905 PMC: 11895001. DOI: 10.1016/j.bsheal.2023.06.002.


Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations.

Xu J, Zhang W, Fu J, Fang X, Gao C, Li C Mil Med Res. 2024; 11(1):78.

PMID: 39676169 PMC: 11648306. DOI: 10.1186/s40779-024-00581-0.


Hantavirus Expansion Trends in Natural Host Populations in Brazil.

Mello J, Muylaert R, Grelle C Viruses. 2024; 16(7).

PMID: 39066316 PMC: 11281686. DOI: 10.3390/v16071154.


Zoonotic with Global Public Health Significance.

Chen R, Gong H, Wang X, Sun M, Ji Y, Tan S Viruses. 2023; 15(8).

PMID: 37632047 PMC: 10459939. DOI: 10.3390/v15081705.


Logistic regression analysis of risk factors for hemorrhagic fever with renal syndrome complicated with acute pancreatitis.

Wang W, Fan D, Quan B, Hou W, Yang J Ann Med. 2023; 55(1):2232355.

PMID: 37431612 PMC: 10337492. DOI: 10.1080/07853890.2023.2232355.


References
1.
Mertz G, Miedzinski L, Goade D, Pavia A, Hjelle B, Hansbarger C . Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis. 2004; 39(9):1307-13. DOI: 10.1086/425007. View

2.
Ermonval M, Baychelier F, Tordo N . What Do We Know about How Hantaviruses Interact with Their Different Hosts?. Viruses. 2016; 8(8). PMC: 4997585. DOI: 10.3390/v8080223. View

3.
Woolhouse M, Brierley L, McCaffery C, Lycett S . Assessing the Epidemic Potential of RNA and DNA Viruses. Emerg Infect Dis. 2016; 22(12):2037-2044. PMC: 5189130. DOI: 10.3201/eid2212.160123. View

4.
Kukkonen S, Vaheri A, Plyusnin A . L protein, the RNA-dependent RNA polymerase of hantaviruses. Arch Virol. 2004; 150(3):533-56. DOI: 10.1007/s00705-004-0414-8. View

5.
Mittler E, Dieterle M, Kleinfelter L, Slough M, Chandran K, Jangra R . Hantavirus entry: Perspectives and recent advances. Adv Virus Res. 2019; 104:185-224. PMC: 6881143. DOI: 10.1016/bs.aivir.2019.07.002. View